Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2425328 | 0.93 | CA1 (0.35) | CA1CA2CA14 | |
| SCHEMBL2437036 | 0.92 | — | — | |
| SCHEMBL12287773 | 0.91 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL12287799 | 0.91 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL2428105 | 0.90 | — | — | |
| SCHEMBL1018058 | 0.90 | CA14 (0.30) | CA14 | |
| SCHEMBL1021807 | 0.90 | — | — | |
| SCHEMBL12287832 | 0.89 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL2429757 | 0.89 | F2 (0.30) | — | |
| SCHEMBL1129973 | 0.88 | CA14 (0.31) | CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017656-B2 | Organic sulfur compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-13 | — | — | US | disclosed |
| US-8017656-B2 | Organic sulfur compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20090186941-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090186941-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-1951664-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES | Sumitomo Chemical Company, Limited (JP) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007060839-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186941-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF | TST, SQOR, TRPA1 | CA1 1954/4885CA2 1862/4885CA14 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.